LAURUSLABS · Health Care · 2026-08-21

Laurus Labs Ltd

7.4★★ GoodStrong +6.1Stage 2 · wk 18In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹1,802
-1.26% today
₹97,364 Cr · Large cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Visit company website →
P/E (TTM)
88.2
Forward 57.9
Earnings Growth (YoY)
+19.4%
Revenue +5.3%
ROE
+17.7%
Profit margin +13.0%
Dividend Yield
0.17%
P/B 14.1
vs 52W High
-3.0%
₹831.6 lo₹1,858 hi
3.0% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 18
1w13w26w
Week 18 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
47.4%
200 DMA: ₹1,222.5 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.62x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +7.7% vs MA50 +12.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #8 of 84 Stage 2 stocks in Health Care by RS. Leading the sector.
Industry
Pharmaceuticals
↑ Building
Stage 2%
56.1%
20d Δ
+5.6pp
1M return
+2.7%
3M return
+10.4%
Industry Stage-2 % · last 20 days
Ranks #8 of 58 Stage 2 stocks in this industry. Top tier.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-29 → 2026-08-21
S2 46w
S2 50w
S2 18w
2023-05-292026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 10w → S2 13w → S3 7w → S2 12w → S3 4w → S2 46w → S3 4w → S2 50w → S3 5w → S2 18w current
Total tracked: 169 weeks across 10 stage runs.
1M
+14.9%
3M
+34.1%
6M
+78.0%
YTD
+66.6%
1Y
+108.9%
Scan Membership
Breakout Watch
Latest: 2026-04-21
3 appearances in last 60 days. First seen: 2024-04-16.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 18 · Vol —x
2026-08-20S2
Wk 17 · Vol —x
2026-08-19S2
Wk 17 · Vol —x
2026-08-18S2
Wk 17 · Vol —x
2026-08-17S2
Wk 17 · Vol —x
2026-08-14S2
Wk 17 · Vol —x
2026-08-13S2
Wk 16 · Vol —x
2026-08-12S2
Wk 16 · Vol —x
2026-08-11S2
Wk 16 · Vol —x
2026-08-10S2
Wk 16 · Vol —x
2026-08-07S2
Wk 16 · Vol —x
2026-08-06S2
Wk 15 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹1,623.4
200 DMA
₹1,222.5
52W High
₹1,858
52W Low
₹831.6
5D Low
₹1,801.8
Resistance levels (recent highs)
20d High
₹1,858
60d High
₹1,858
120d High
₹1,858
250d High
₹1,858
Next resistance
+3.1%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.